Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Widschwendter, M; Jones, A; Evans, I; Reisel, D; Dillner, J; Sundström, K; Steyerberg, EW; Vergouwe, Y; Wegwarth, O; Rebitschek, FG; +16 more... Siebert, U; Sroczynski, G; de Beaufort, ID; Bolt, I; Cibula, D; Zikan, M; Bjørge, L; Colombo, N; Harbeck, N; Dudbridge, F; Tasse, AM; Knoppers, BM; Joly, Y; Teschendorff, AE; Pashayan, N; FORECEE (4C) Consortium; (2018) Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nature reviews Clinical oncology. ISSN 1759-4774 DOI: https://doi.org/10.1038/nrclinonc.2018.30

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1038/nrclinonc.2018.30

Abstract

Share

Download

Filename: Epigenome-based cancer risk prediction_GREEN _AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar